FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161454957> ?p ?o ?g. }

• W3161454957 abstract "The ascarid, Toxocara canis, is a common and important zoonotic intestinal nematode parasite that infects dogs globally. An effective treatment that kills any pre-patent stages of immature T. canis could additionally reduce or eliminate the development of patent infections that can result in clinical disease in infected dogs and would further reduce environmental contamination of eggs. Two randomized, blinded, GCP-compliant, pivotal laboratory dose confirmation studies were conducted to assess the effectiveness and safety of a new novel combination of lotilaner and milbemycin oxime tablets (Credelio Plus) administered orally to dogs that were experimentally infected with immature (L4 or immature adult [L5]) stages of T. canis.The commercial tablet formulation of Credelio Plus® was administered in a time frame relative to inoculation with infective eggs. This allowed for effectiveness to be assessed against each specific immature stage of T. canis. In each study, dogs were randomized and allocated to one of four treatment groups. Each treatment group contained ten dogs that had been experimentally inoculated on Day 0 with infective T. canis eggs and then were dosed once on Day 14 or Day 24 using either placebo tablets or Credelio Plus tablets (IP) to provide minimum dosages of 0.75 mg/kg of milbemycin oxime and 20 mg/kg of lotilaner. All dogs were necropsied 5 or 6 days after their respective treatment. At necropsy, all nematodes recovered from the gastrointestinal tract were counted by species and stage.In both dose confirmation studies using geometric mean worm counts, effectiveness of Credelio Plus was ≥ 98.6% and ≥ 96.8% against L4 larval stage T. canis and immature adult [L5] T. canis in both studies, respectively.These studies demonstrated that the Credelio Plus combination tablet administered orally to dogs was highly efficacious against experimental infections with L4 and immature adult [L5] stages of T. canis." @default.
• W3161454957 created "2021-05-24" @default.
• W3161454957 creator A5003374751 @default.
• W3161454957 creator A5044710952 @default.
• W3161454957 creator A5048432397 @default.
• W3161454957 creator A5072757285 @default.
• W3161454957 creator A5074385286 @default.
• W3161454957 creator A5086301944 @default.
• W3161454957 date "2021-05-17" @default.
• W3161454957 modified "2023-10-11" @default.
• W3161454957 title "Effectiveness of Credelio® Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs" @default.
• W3161454957 cites W1980472646 @default.
• W3161454957 cites W1983814892 @default.
• W3161454957 cites W1991063707 @default.
• W3161454957 cites W2008088759 @default.
• W3161454957 cites W2012112841 @default.
• W3161454957 cites W2028627924 @default.
• W3161454957 cites W2029188300 @default.
• W3161454957 cites W2038038863 @default.
• W3161454957 cites W2045956588 @default.
• W3161454957 cites W2048362058 @default.
• W3161454957 cites W2052658374 @default.
• W3161454957 cites W2064465051 @default.
• W3161454957 cites W2065349573 @default.
• W3161454957 cites W2094370096 @default.
• W3161454957 cites W2094790558 @default.
• W3161454957 cites W2102703096 @default.
• W3161454957 cites W2126079065 @default.
• W3161454957 cites W2139996152 @default.
• W3161454957 cites W2142529981 @default.
• W3161454957 cites W2168541751 @default.
• W3161454957 cites W2607011012 @default.
• W3161454957 cites W2765150341 @default.
• W3161454957 cites W2765610418 @default.
• W3161454957 cites W2765668609 @default.
• W3161454957 cites W2765754247 @default.
• W3161454957 cites W2766323613 @default.
• W3161454957 cites W2766456511 @default.
• W3161454957 cites W2766514631 @default.
• W3161454957 cites W2867927502 @default.
• W3161454957 cites W2886824964 @default.
• W3161454957 cites W2889101320 @default.
• W3161454957 cites W2894963568 @default.
• W3161454957 cites W2931435087 @default.
• W3161454957 cites W2971676613 @default.
• W3161454957 cites W3000255452 @default.
• W3161454957 cites W3019684603 @default.
• W3161454957 cites W3030528474 @default.
• W3161454957 cites W4240630809 @default.
• W3161454957 cites W4252170279 @default.
• W3161454957 doi "https://doi.org/10.1186/s13071-021-04762-x" @default.
• W3161454957 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8127296" @default.
• W3161454957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34001224" @default.
• W3161454957 hasPublicationYear "2021" @default.
• W3161454957 type Work @default.
• W3161454957 sameAs 3161454957 @default.
• W3161454957 citedByCount "2" @default.
• W3161454957 countsByYear W31614549572021 @default.
• W3161454957 countsByYear W31614549572023 @default.
• W3161454957 crossrefType "journal-article" @default.
• W3161454957 hasAuthorship W3161454957A5003374751 @default.
• W3161454957 hasAuthorship W3161454957A5044710952 @default.
• W3161454957 hasAuthorship W3161454957A5048432397 @default.
• W3161454957 hasAuthorship W3161454957A5072757285 @default.
• W3161454957 hasAuthorship W3161454957A5074385286 @default.
• W3161454957 hasAuthorship W3161454957A5086301944 @default.
• W3161454957 hasBestOaLocation W31614549571 @default.
• W3161454957 hasConcept C142724271 @default.
• W3161454957 hasConcept C151730666 @default.
• W3161454957 hasConcept C162156334 @default.
• W3161454957 hasConcept C165901193 @default.
• W3161454957 hasConcept C180032290 @default.
• W3161454957 hasConcept C18903297 @default.
• W3161454957 hasConcept C203014093 @default.
• W3161454957 hasConcept C204787440 @default.
• W3161454957 hasConcept C27081682 @default.
• W3161454957 hasConcept C2776908094 @default.
• W3161454957 hasConcept C2777390839 @default.
• W3161454957 hasConcept C2777541303 @default.
• W3161454957 hasConcept C2778830712 @default.
• W3161454957 hasConcept C2779557943 @default.
• W3161454957 hasConcept C42972112 @default.
• W3161454957 hasConcept C71924100 @default.
• W3161454957 hasConcept C86803240 @default.
• W3161454957 hasConcept C98274493 @default.
• W3161454957 hasConceptScore W3161454957C142724271 @default.
• W3161454957 hasConceptScore W3161454957C151730666 @default.
• W3161454957 hasConceptScore W3161454957C162156334 @default.
• W3161454957 hasConceptScore W3161454957C165901193 @default.
• W3161454957 hasConceptScore W3161454957C180032290 @default.
• W3161454957 hasConceptScore W3161454957C18903297 @default.
• W3161454957 hasConceptScore W3161454957C203014093 @default.
• W3161454957 hasConceptScore W3161454957C204787440 @default.
• W3161454957 hasConceptScore W3161454957C27081682 @default.
• W3161454957 hasConceptScore W3161454957C2776908094 @default.
• W3161454957 hasConceptScore W3161454957C2777390839 @default.
• W3161454957 hasConceptScore W3161454957C2777541303 @default.
• W3161454957 hasConceptScore W3161454957C2778830712 @default.
• W3161454957 hasConceptScore W3161454957C2779557943 @default.
• W3161454957 hasConceptScore W3161454957C42972112 @default.

• next